Ultrasound Guıded Adductor Canal Block vs Perıcapsular Nerve Group Block in Knee Artroplasty
Launched by BURSA CITY HOSPITAL · Jan 3, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different pain relief methods for patients undergoing knee replacement surgery (also known as knee arthroplasty). The two methods being compared are called the Adductor Canal Block (ACB) and the Pericapsular Nerve Group Block (PENG). Both techniques aim to help manage postoperative pain, which can be quite severe after surgery due to the procedure and the new joint being placed.
To participate in this trial, you should be between 18 and 85 years old and classified as having a low to moderate risk for surgery (according to the American Society of Anesthesiologists). You should also be scheduled for total knee arthroplasty under spinal anesthesia. However, if you have certain medical conditions, such as a bleeding disorder, are taking blood-thinning medications, or have allergies to local anesthetics or opioids, you may not be eligible. Participants can expect to receive either of the pain relief methods during their surgery and will be monitored for how well it works in reducing pain afterward. This study is currently recruiting participants and aims to improve the way pain is managed after knee surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anesthesiologists (ASA) classification I-II
- • Scheduled for total knee arthroplasty under spinal anesthesia
- Exclusion Criteria:
- • history of bleeding diathesis
- • receiving anticoagulant treatment,
- • known local anesthetics and opioid allergy,
- • infection of the skin at the site of the needle puncture,
- • pregnancy or lactation,
- • patients who do not accept the procedur
About Bursa City Hospital
Bursa City Hospital is a premier healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a robust infrastructure, the hospital fosters collaboration between healthcare professionals and researchers to explore new therapies and treatment modalities. By participating in diverse clinical studies, Bursa City Hospital aims to contribute to the global medical community while ensuring the highest standards of safety and ethical practices in all research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bursa, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported